Pharmya will be present at the International Pharmacovigilance Day conference in Barcelona on 12th and 13th of June 2019. Meet us there!
Pharmya will be present at the International Pharmacovigilance Day conference in Barcelona on 12th and 13th of June 2019. Meet us there!
Pharmya attends the Joint MEB/DIA Excellence in Pharmacovigilance training
Pharmya attends the Joint MEB/DIA Excellence in Pharmacovigilance training
EMA releases practical guidance for procedures related to Brexit for centralised products
EMA releases practical guidance for procedures related to Brexit for centralised products Document
We are certified according to ISO 9001:2015
We are ISO 9001 : 2015 certified, This means that Pharmya has implemented high quality standards. all processes and procedures have been carefully designed and quality-tested according to international standards.
Pharmacovigilance Programme Update / EMA October 2015
This 5th Update captures the important progress made in the development of the pharmacovigilance information systems and services. These systems will contribute to public health through optimisation of the safe and effective use of medicines. They should also facilitate pharmacovigilance,…
ANSM Lancement de la Phase Pilote / Nouveau règlement européen relatif aux essais cliniques
L’application du Règlement UE n° 536/2014 impose de nouvelles modalités de travail pour les autorités compétentes et les Comités d’éthique des Etats membres. Son entrée en vigueur interviendra au plus tôt le 28 mai 2016, sous réserve de la mise…
GVP Module IV- Pharmacovigilance Audits
The EMA releases an updated version of the GVP Module IV, Pharmacovigilance audits. Changes include: Addition of an explanatory note for the definition of audit in footnote 3 on page 5; Editorial improvements in line with the overall GVP style.…